Clinigen Group (CLIN)

Sector:

Food Pharmacy Retail

Index:

FTSE AIM 50

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 760.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 853.50
  • 52 Week Low: 492.75
  • Currency: UK Pounds
  • Shares Issued: 115.09m
  • Volume: 595,142
  • Market Cap: 874.72m
  • Beta: 1.33

Clinigen Group Overview

Clinigen Group is in the food pharmacy retail sector and is currently trading at 760.00p per share. In the last year Clinigen Group's share price has ranged from 492.75p to 853.50p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.5% 0.6%
Div Cover 8.8 8.6
Op Mrgn 5.9% 16.1%
ROCE 98.6%  
Latest F'cast
P/E 21.7 18.6
PEG 0.9 1.1
Pr/Revenue 2.6 2.6
Pr/Book 3.7  
Latest F'cast
Revenue 84.3% -1.2%
PBT 91.6% 240.2%
EPS 25.0% 16.5%
DPS 17.6% 18.0%

Clinigen Group Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-12 82.15 10.25 13.40p n/a n/a n/a n/a 0.0%
30-Jun-13 122.58 14.51 22.18p 13.5 0.2 +66% 2.60p 0.9%
30-Jun-14 126.64 21.24 24.50p 15.4 1.5 +10% 3.10p 0.8%
30-Jun-15 184.40 8.30 28.00p 22.3 1.6 +14% 3.40p 0.5%
30-Jun-16 339.90 15.90 35.00p 17.3 0.7 +25% 4.00p 0.7%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Clinigen Group Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-17 335.88 54.09 40.78p 18.6 1.1 +16% 4.72p 0.6%
30-Jun-18 370.35 63.80 46.81p 16.2 1.1 +15% 5.44p 0.7%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

Clinigen Group Company Announcements

Launch of a European Patient Access programme 16-Mar-2017 07:00 RNS
Half-year Report 15-Mar-2017 07:00 RNS
Holding(s) in Company 09-Mar-2017 08:58 RNS

Latest Clinigen Group Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Clinigen Group Market Data

Currency UK Pounds
Share Price 760.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 853.50
52 Week Low 492.75
Volume 595,142
Shares Issued 115.09m
Market Cap 874.72m
Beta 1.33

Clinigen Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
82.52% below the market average82.52% below the market average82.52% below the market average82.52% below the market average82.52% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Price Trend
64.24% above the market average64.24% above the market average64.24% above the market average64.24% above the market average64.24% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Income
88.71% below the market average88.71% below the market average88.71% below the market average88.71% below the market average88.71% below the market average
62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average
Growth
86.05% above the market average86.05% above the market average86.05% above the market average86.05% above the market average86.05% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Clinigen Group Dividends

  Latest Previous
  Interim Final
Ex-Div 23-Mar-17 03-Nov-16
Paid 13-Apr-17 25-Nov-16
Amount 1.60p 2.70p

Trades for 24-Mar-2017

Time Volume / Share Price
17:09 3,537 @ 760.06p
17:02 1,258 @ 760.96p
16:56 1,356 @ 761.09p
16:53 1,508 @ 760.34p
16:53 6 @ 760.25p

Clinigen Group Key Personnel

CFO Martin Abell

Top of Page